These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23109915)

  • 1. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.
    Patel MM; Clark AD; Sanderson CF; Tate J; Parashar UD
    PLoS Med; 2012; 9(10):e1001330. PubMed ID: 23109915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
    Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
    Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
    Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
    BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.
    Debellut F; Clark A; Pecenka C; Tate J; Baral R; Sanderson C; Parashar U; Atherly D
    Lancet Glob Health; 2021 Jul; 9(7):e942-e956. PubMed ID: 33891885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential intussusception risk versus benefits of rotavirus vaccination in the United States.
    Desai R; Cortese MM; Meltzer MI; Shankar M; Tate JE; Yen C; Patel MM; Parashar UD
    Pediatr Infect Dis J; 2013 Jan; 32(1):1-7. PubMed ID: 22929172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.
    Escolano S; Mueller JE; Tubert-Bitter P
    Euro Surveill; 2020 Aug; 25(33):. PubMed ID: 32820718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
    Janko MM; Joffe J; Michael D; Earl L; Rosettie KL; Sparks GW; Albertson SB; Compton K; Pedroza Velandia P; Stafford L; Zheng P; Aravkin A; Kyu HH; Murray CJL; Weaver MR
    Vaccine; 2022 Jun; 40(28):3903-3917. PubMed ID: 35643565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benefit-risk analysis of rotavirus vaccination, France, 2015.
    Lamrani A; Tubert-Bitter P; Hill C; Escolano S
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
    Bruun T; Watle SSV; Tveteraas IH; Flem E
    Vaccine; 2019 Sep; 37(38):5717-5723. PubMed ID: 31255303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
    Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.
    Ratu FT; Reyburn R; Tuivaga E; Tuiketei A; Jenkins K; Mulholland K; Jenney A; Russell F
    Sci Rep; 2018 Jul; 8(1):11194. PubMed ID: 30046133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N
    Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the global impact of rotavirus vaccines on child mortality.
    Clark A; Mahmud S; Debellut F; Pecenka C; Jit M; Perin J; Tate J; Soeters HM; Black RE; Santosham M; Sanderson C
    Int J Infect Dis; 2023 Dec; 137():90-97. PubMed ID: 37863311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.